Toome-based off-site construction firm P McVey Building Systems is investing £1.4 million to scale its operations into Britain, following significant growth in markets in the Republic.
The move will lead to the creation of 12 jobs at the firm, founded by Pat McVey in 1987 and is now managed by his sons Adrian and Mike.
The award-winning firm (www.pmcveybuildingsystems.com), which specialises in off-site modular buildings for the healthcare, education, and commercial sectors, has been supported in its growth plans by Invest NI
Commercial director Mike McVey said: “Over the last decade, our innovative approach to off-site construction has led us to significantly expand our product range which now includes plant room pods and pharmaceutical pods.
“This year, we will complete the first hybrid operating theatre in Beaumont Hospital in Dublin, utilising modern off-site construction methods. Additionally, we’ve made strides in improving our fire certification, testing over and above industry standards.
“We have partnered closely with Invest NI over the years, and its support has been instrumental in our growth. With its assistance, we are recruiting 12 new staff, which will bolster our presence in GB by enabling us to produce a range of stock hire buildings suitable for easy adaptation for new customers in GB and Ireland.”
Roles on offer include a commercial finance director, quantity surveyors, contracts managers, sales, and production staff.
Invest NI director Gráinne Moody said: “P McVey’s commitment to continuous improvement, innovation, and expansion has established it as a leader in the modular market on the island of Ireland. The company’s strategy to develop smarter products and maintain a competitive edge is impressive.
“With over half of its sales being exports, predominantly to the Republic of Ireland, P McVey has demonstrated a dedication to growth and excellence.
“Our support over the past five years for technical assistance and job creation has enabled the company to focus on building its unique selling proposition, and we look forward to continuing to work with the company as it ventures into new markets.”
The company’s latest accounts show that sales in 2023 rose to £16.8 million from £12.7 million the year before, and pre-tax profit increased from £2.4m to £3.3m.
